CU20090172A7 - Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular - Google Patents

Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular

Info

Publication number
CU20090172A7
CU20090172A7 CUP2009000172A CU20090172A CU20090172A7 CU 20090172 A7 CU20090172 A7 CU 20090172A7 CU P2009000172 A CUP2009000172 A CU P2009000172A CU 20090172 A CU20090172 A CU 20090172A CU 20090172 A7 CU20090172 A7 CU 20090172A7
Authority
CU
Cuba
Prior art keywords
tricyclic
derivatives
ortho
dihydropyridine
nervous system
Prior art date
Application number
CUP2009000172A
Other languages
English (en)
Other versions
CU20090172A6 (es
CU23879B1 (es
Inventor
Reyes Yamila Verdecia
Rodríguez Estael Ochoa
Reyes Alberto Ruiz
Figueredo Yanier Núñez
Domínguez Carmen Carrillo
Morales Juan Enrique Tacoronte
Gutiérrez Livan Lázaro Alba
Andreu Gilberto Lázaro Pardo
Original Assignee
Ct De Investigación Y Desarrollo De Medicamentos
Síntesis Orgánica De La Facultad De Química De La Universidad De La Habana Lab De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct De Investigación Y Desarrollo De Medicamentos, Síntesis Orgánica De La Facultad De Química De La Universidad De La Habana Lab De filed Critical Ct De Investigación Y Desarrollo De Medicamentos
Priority to CU20090172A priority Critical patent/CU20090172A6/es
Priority to CA2777209A priority patent/CA2777209C/en
Priority to KR1020127011917A priority patent/KR20120093940A/ko
Priority to JP2012532450A priority patent/JP2013507329A/ja
Priority to PCT/CU2010/000004 priority patent/WO2011041989A2/es
Priority to US13/500,983 priority patent/US9315497B2/en
Priority to CN2010800556597A priority patent/CN102656171A/zh
Priority to EP10821598.9A priority patent/EP2487174A4/en
Publication of CU20090172A7 publication Critical patent/CU20090172A7/es
Publication of CU20090172A6 publication Critical patent/CU20090172A6/es
Priority to ZA2012/03295A priority patent/ZA201203295B/en
Publication of CU23879B1 publication Critical patent/CU23879B1/es
Priority to US14/282,111 priority patent/US10138231B2/en
Priority to US16/171,046 priority patent/US20190092769A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se relaciona con la química, la farmacéutica y en particular con la obtención de nuevas entidades moleculares, derivados tricíclicos y tetracíclicos del tipo benzodiazepinas, piridodiazepinas y pirimidodiazepinas fusionadas a derivados de 1,4-dihidropiridinas, con acción sobre el sistema nervioso central y vascular. A partir de derivados que contienen un anillo de dihidropiridina, mediante reacciones con compuestos del tipo orto-fenilendiaminas, orto-diaminopiridinas y orto-diaminopirimidinas, así como posteriores transformaciones a algunos de ellos, se obtienen derivados tricíclicos y tetracíclicos de fórmula general I-XII que contienen un núcleo de diazepina o diazepinona fusionadas a un núcleo de 1,4-dihidropiridina, donde el ciclo A, es un anillo de benceno, piridina o pirimidina sustituido o no. Estas entidades moleculares presentan acción GABAérgica y moduladora de los canales de calcio, utilizables en el tratamiento de las enfermedades cardiovasculares, cerebrovasculares, neurodegenerativas, neuropsiquiátricas y neurológicas. ESPACIO PARA LA FÓRMULA
CU20090172A 2009-10-09 2009-10-09 Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular CU20090172A6 (es)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CU20090172A CU20090172A6 (es) 2009-10-09 2009-10-09 Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
US13/500,983 US9315497B2 (en) 2009-10-09 2010-10-08 Tricyclic and tetracyclic systems with activity on the central nervous and vascular systems
KR1020127011917A KR20120093940A (ko) 2009-10-09 2010-10-08 중추신경계 및 혈관계에 대한 활성을 갖는 트리시클릭 및 테트라시클릭 시스템
JP2012532450A JP2013507329A (ja) 2009-10-09 2010-10-08 脈管系および中枢神経系に作用する三環系化合物および四環系化合物
PCT/CU2010/000004 WO2011041989A2 (es) 2009-10-09 2010-10-08 Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
CA2777209A CA2777209C (en) 2009-10-09 2010-10-08 Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems
CN2010800556597A CN102656171A (zh) 2009-10-09 2010-10-08 对血管系统和中枢神经系统起作用的三环和四环系统
EP10821598.9A EP2487174A4 (en) 2009-10-09 2010-10-08 TRICYCLIC AND TETRACYCLIC SYSTEMS WITH EFFECT ON THE CENTRAL NERVOUS AND VACUUM SYSTEM
ZA2012/03295A ZA201203295B (en) 2009-10-09 2012-05-07 Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems
US14/282,111 US10138231B2 (en) 2009-10-09 2014-05-20 Tricyclic and tetracyclic systems acting upon the vascular and central nervous systems
US16/171,046 US20190092769A1 (en) 2009-10-09 2018-10-25 Tricyclic and tetracyclic systems acting upon the vascular and central nervous systems

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20090172A CU20090172A6 (es) 2009-10-09 2009-10-09 Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular

Publications (3)

Publication Number Publication Date
CU20090172A7 true CU20090172A7 (es) 2011-10-05
CU20090172A6 CU20090172A6 (es) 2011-10-05
CU23879B1 CU23879B1 (es) 2013-04-19

Family

ID=45000047

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20090172A CU20090172A6 (es) 2009-10-09 2009-10-09 Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular

Country Status (9)

Country Link
US (3) US9315497B2 (es)
EP (1) EP2487174A4 (es)
JP (1) JP2013507329A (es)
KR (1) KR20120093940A (es)
CN (1) CN102656171A (es)
CA (1) CA2777209C (es)
CU (1) CU20090172A6 (es)
WO (1) WO2011041989A2 (es)
ZA (1) ZA201203295B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201215033D0 (en) 2012-08-23 2012-10-10 Novartis Ag Diazepinone derivatives
GB201510010D0 (en) 2015-06-09 2015-07-22 King S College London PDD and BPD compounds
GB201514928D0 (en) 2015-08-21 2015-10-07 King S College London PDD compounds
US20180339985A1 (en) 2015-08-21 2018-11-29 Femtogenix Limited Pdd compounds
CU20160058A7 (es) 2016-05-04 2017-12-08 Centro De Investigación Y Desarrollo De Medicamentos (Cidem) Organizacion Superior De Desarrollo Emp Derivado de benzodiazepina con actividad sobre el sistema nervioso central y vascular
CU20190114A7 (es) 2019-12-26 2021-08-06 Centro De Investig Y Desarrollo De Medicamentos Cidem Combinación para simultáneamente incrementar la eficacia analgésica de la morfina y reducir su dependencia física
KR20230066328A (ko) * 2020-09-09 2023-05-15 (주)스파크바이오파마 신규 피리미도디아제핀 유도체 및 이의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780047A (en) * 1972-07-05 1973-12-18 Squibb & Sons Inc Derivatives of pyrazolo(3',4'-2,3)pyrido(4,5-e)b-benzo-1,5-diazepines
US4012373A (en) * 1972-09-22 1977-03-15 E. R. Squibb & Sons, Inc. Pyrazolo[3',4'-2,3]pyrido[4,5-e]b-benzo-1,5-diazepinones
US4970207A (en) 1988-07-07 1990-11-13 Fujisawa Pharmaceutical Company, Ltd. Benzodiazepine derivatives
US5571809A (en) * 1989-04-20 1996-11-05 Boehringer Ingelheim Pharmaceuticals, Inc. The treatment of HIV-1 infection using certain pyridodiazepines
EP0491218A1 (en) 1990-12-17 1992-06-24 F. Hoffmann-La Roche Ag Benzodiazepinones
EP0498290B1 (en) * 1991-02-07 1996-09-18 Boehringer Ingelheim Pharmaceuticals Inc. Pyridobenzodiazepines, dipyrido [3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection
GEP20001968B (en) 1992-01-21 2000-03-05 Glaxo Spa Arilthio Compounds as Antibacterial and Antiviral Agents
ATE169007T1 (de) 1992-01-21 1998-08-15 Glaxo Wellcome Spa 1,5-benzodiazepinderivate und deren verwendung in heilmittel
AU3443593A (en) 1992-02-13 1993-09-03 Upjohn Company, The 4-oxo- and 4H-imidazo(5,1-C)(1,4)benzoxazines useful as benzodiazepine receptor-binding agents
ES2139933T3 (es) 1994-08-18 2000-02-16 Merck & Co Inc 2,3-dihidro-1-(2,2,2-trifluoroetil)-2-oxo-5-fenil-1h-1,4-benzodiacepinas.
DK0771198T3 (da) 1994-08-31 2002-04-22 Lilly Co Eli Dihydro-2,3-benzodiazepinderivater
EG24221A (en) 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
TWI239333B (en) 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators
CA2508542A1 (en) * 2002-12-03 2004-06-17 Vela Pharmaceuticals, Inc. Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5h-2,3-benzodiazepine and uses thereof

Also Published As

Publication number Publication date
WO2011041989A2 (es) 2011-04-14
CA2777209A1 (en) 2011-04-14
CN102656171A (zh) 2012-09-05
US20140275042A1 (en) 2014-09-18
EP2487174A4 (en) 2013-05-08
US9315497B2 (en) 2016-04-19
WO2011041989A3 (es) 2011-09-15
ZA201203295B (en) 2014-10-29
CU20090172A6 (es) 2011-10-05
US20190092769A1 (en) 2019-03-28
CU23879B1 (es) 2013-04-19
KR20120093940A (ko) 2012-08-23
US10138231B2 (en) 2018-11-27
US20120202791A1 (en) 2012-08-09
CA2777209C (en) 2016-11-22
JP2013507329A (ja) 2013-03-04
EP2487174A2 (en) 2012-08-15

Similar Documents

Publication Publication Date Title
CU20090172A7 (es) Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
NI201300071A (es) IMIDAZO [5, 1-f] [1, 2, 4] TRIAZINAS PARA EL TRATAMIENTO DE TRASTORNOS NEUROLÓGICOS
NI201900060A (es) Inhibidores de moléculas pequeñas de la familia de quinasa jak
NI201900061A (es) Imidazopirrolopiridina como inhibidores de la familia de quinasas jak
CL2009000975A1 (es) Compuestos derivados de quinuclidina, ligandos del receptor de acetilcolina a7; su composicion farmaceutica; su uso para el tratamiento de trastornos del sistema nervioso central, en especial afectivos y neurodegenerativos, enfermedades tales como esquizofrenia y alzheimer.
CR8718A (es) Compuesto de morfolina sustituida para el tratamiento de trastornos del sistema nervioso central
PE20100730A1 (es) Benzazepinas fusionadas como ligandos de receptor de acetilcolina nicotinico neuronal
CO7240375A2 (es) Compuestos tricíclicos sustituidos como inhibidores del fgfr
Reekie et al. Synthesis of biologically active seven-membered-ring heterocycles
CL2011002837A1 (es) Compuestos derivados de 1,2,4-triazolo[4,3-a]piridina, moduladores alostericos positivos de receptores mglur2; composicion farmaceutica; proceso para prepararla; y su uso en el tratamiento o la prevencion de un trastorno del sistema nervioso central tal como la ansiedad, esquizofrenia y migraña, entre otros.
CO6321264A2 (es) Derivados de 1-heterociclilo-1,5-dihidro-pirazolo[3,4-d]pirimidin-4-ona y su uso como moduladores de la pde9a
CR20120273A (es) OCTAHIDROPIRROLO[3,4-c]PIRROLOS DISUSTITUIDOS COMO MODULADORES DEL RECEPTOR DE OREXINA
EA201270498A1 (ru) 8-этил-6-(арил)пиридо[2,3-d]пиримидин-7(8h)-оны для лечения заболеваний цнс
CO6531468A2 (es) Derivados de imidazo[1,2-b] piridazina y su uso como inhibidores de pde 10
UY32426A (es) Derivados bicilicos para uso en el tratamiento de enfermedades relacionadas al receptor de androgeno
GT200600422A (es) Derivados de carboxamida como antagonistas del receptor muscarinico
UY31644A1 (es) Imidazolina -2,4-dionas sustituidas, procesos para su preparación, medicamentos que comprenden estos compuestos y uso de los mismos.
CO6592112A2 (es) Derivadosde piridina triciclicos, medicamentos que contienen tales compuestos, su uso y proceso para su separaciòn
CO2018003756A2 (es) Derivados de éter cíclico de pirazolo[1,5-a]pirimidin-3-carboxiamida
CO2018011927A2 (es) Compuesto fenólico y combinación del mismo con una benzodiazepina fusionada a 1,4-dihidropiridina para el tratamiento de afecciones del sistema nervioso central y vascular
Bardají et al. Flexible approach to Stemona alkaloids: total syntheses of (−)-stemospironine and three new diastereoisomeric analogs
Li et al. Cephalofortunone, a structurally unique Cephalotaxus alkaloid from Cephalotaxus fortune Hook. f.
CL2018003113A1 (es) Derivado de benzodiazepina con actividad sobre el sistema nervioso central y vascular.
CU20110244A7 (es) Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios
UY34281A (es) "1,4-diazabiciclo[3.2.2]nonanos como ligandos de receptores nicotínicos neuronales de acetilcolina

Legal Events

Date Code Title Description
FG Grant of patent